Nanomedicine,
Год журнала:
2024,
Номер
20(2), С. 225 - 241
Опубликована: Дек. 26, 2024
The
use
of
nanoparticles
(NPs)
in
treatment
diseases
have
increased
exponentially
recently,
giving
rise
to
the
science
nanomedicine.
safety
these
NPs
humans
has
also
led
nanotoxicology.
Due
a
dearth
both
readily
available
models
and
precise
bio-dispersion
characterization
techniques,
nanotoxicological
research
obviously
been
constrained.
However,
ensuing
years
were
notable
for
emergence
improved
synthesis
methods
tools.
Major
advances
made
linking
certain
physical
variables,
paralleling
improvements
size,
shape,
or
coating
factors
resulting
physiological
reactions.
Although
significant
progress
contribution
development
nanotoxicology,
however,
it
faces
numerous
difficulties
technical
constraints
distinct
from
those
conventional
toxicological
assessment
as
attempts
improve
therapeutic
effects
medicines.
Determining
thorough
standards,
standardizing
dosimetry,
assessing
kinetics
ions
dissolving
enhancing
accuracy
vitro-in
vivo
correlation
efficiency,
defining
restrictions
on
exposure
protection
are
some
most
important
pressing
concerns.
This
article
will
explore
past
advancement
potential
prospects
standard
models,
emphasizing
findings
earlier
studies
examining
current
challenges,
insight
way
forward.
Journal of Nanobiotechnology,
Год журнала:
2024,
Номер
22(1)
Опубликована: Ноя. 15, 2024
Abstract
Nanotechnology
holds
immense
promise
in
revolutionising
healthcare,
offering
unprecedented
opportunities
diagnostics,
drug
delivery,
cancer
therapy,
and
combating
infectious
diseases.
This
review
explores
the
multifaceted
landscape
of
nanotechnology
healthcare
while
addressing
critical
aspects
safety
environmental
risks
associated
with
its
widespread
application.
Beginning
an
introduction
to
integration
we
first
delved
into
categorisation
various
materials
employed,
setting
stage
for
a
comprehensive
understanding
potential.
We
then
proceeded
elucidate
diverse
applications
nanotechnology,
spanning
medical
tissue
engineering,
targeted
gene
development
antimicrobial
agents.
The
discussion
extended
current
situation
surrounding
clinical
translation
commercialisation
these
cutting-edge
technologies,
focusing
on
nanotechnology-based
products
that
have
been
approved
globally
date.
also
discussed
considerations
nanomaterials,
both
terms
human
health
impact.
presented
vivo
nanomaterial
exposure,
relation
transport
mechanisms,
oxidative
stress,
physical
interactions.
Moreover,
highlighted
risks,
acknowledging
potential
implications
ecosystems
biodiversity.
Lastly,
strived
offer
insights
regulatory
governing
across
different
regions
globally.
By
synthesising
perspectives,
underscore
imperative
balancing
innovation
stewardship,
charting
path
forward
responsible
healthcare.
Graphical
abstract
Cancer Nanotechnology,
Год журнала:
2025,
Номер
16(1)
Опубликована: Янв. 17, 2025
Emphasizing
the
significance
of
cancer-associated
fibroblasts
(CAFs),
non-malignant
yet
pivotal
players
within
tumor
microenvironment
(TME),
this
review
illuminates
role
inflammatory
subtype
(iCAF)
as
catalysts
in
cancer
proliferation,
metastasis,
and
therapeutic
resistance.
Given
their
paramount
importance,
targeting
CAFs
emerges
a
robust
strategy
evolving
landscape
immunotherapy.
Nanomaterials,
distinguished
by
unique
features
malleability,
hold
considerable
promise
biomedicine,
especially
precision-oriented
domain
therapy.
Their
aptitude
for
modulating
immune
responses,
amplifying
drug
efficacy
through
precise
delivery,
discerningly
focusing
on
cells
TME
situates
nanomaterials
formidable
tools
to
transcend
boundaries
set
conventional
treatments.
This
scrutinizes
convoluted
interplay
among
CAFs,
cells,
TME.
It
further
showcases
widely
utilized
management.
We
underscore
potential
nanoscale
delivery
systems
directed
at
underscoring
transformative
power
revolutionizing
therapies,
enhancing
precision,
culminating
improved
patient
outcomes.
Frontiers in Toxicology,
Год журнала:
2024,
Номер
6
Опубликована: Ноя. 26, 2024
Chemical
risk
assessment
plays
a
pivotal
role
in
safeguarding
public
health
and
environmental
safety
by
evaluating
the
potential
hazards
risks
associated
with
chemical
exposures.
In
recent
years,
convergence
of
artificial
intelligence
(AI),
machine
learning
(ML),
omics
technologies
has
revolutionized
field
assessment,
offering
new
insights
into
toxicity
mechanisms,
predictive
modeling,
management
strategies.
This
perspective
review
explores
synergistic
AI/ML
deciphering
clastogen-induced
genomic
instability
for
carcinogenic
prediction.
We
provide
an
overview
key
findings,
challenges,
opportunities
integrating
highlighting
successful
applications
case
studies
across
diverse
sectors.
From
predicting
genotoxicity
mutagenicity
to
elucidating
molecular
pathways
underlying
carcinogenesis,
integrative
approaches
offer
comprehensive
framework
understanding
exposures
mitigating
risks.
Future
perspectives
advancing
cancer
prevention
through
data
integration,
advanced
techniques,
translational
research,
policy
implementation
are
discussed.
By
implementing
capabilities
technologies,
researchers
policymakers
can
enhance
protection,
inform
regulatory
decisions,
promote
sustainable
development
healthier
future.
The
integration
of
immunotoxicity
data
into
chemical
risk
assessment
paradigms
is
essential
for
comprehensively
evaluating
the
potential
health
hazards
posed
by
exposures.
This
review
provides
a
comprehensive
overview
methodologies,
challenges,
and
future
directions
integrating
frameworks.
It
discusses
fundamental
principles
immunotoxicology
its
relevance
to
assessment,
highlighting
critical
roles
immune
system
in
defense
against
harmful
agents.
Next,
we
explore
traditional
frameworks,
including
exposure
hazard
identification,
dose–response
characterization,
need
incorporating
endpoints
enhance
characterization
estimation.
Subsequently,
delve
modelling
immunotoxicity,
elucidating
principles,
methods,
case
studies
illustrating
relationships
extrapolation
from
animal
humans.
Furthermore,
discuss
focusing
on
identification
immunotoxic
hazards,
evaluation
endpoints,
utilization
immunological
biomarkers
assessment.
We
then
examine
cumulative
strategies,
presenting
conceptual
framework
assessing
risks
multiple
exposures
methods
different
chemicals.
Lastly,
emerging
trends
high-throughput
screening
assays,
omics
technologies,
computational
modelling,
alternative
testing
along
with
regulatory
implications
research
needs.
valuable
insights
researchers,
regulators,
stakeholders
involved
public
protection,
facilitating
development
evidence-based
strategies
safeguarding
human
associated
Advanced Science,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 3, 2025
Abstract
Unexpected
toxicity
has
become
a
significant
obstacle
to
drug
candidate
development,
accounting
for
30%
of
discovery
failures.
Traditional
assessment
through
animal
testing
is
costly
and
time‐consuming.
Big
data
artificial
intelligence
(AI),
especially
machine
learning
(ML),
are
robustly
contributing
innovation
progress
in
toxicology
research.
However,
the
optimal
AI
model
different
types
usually
varies,
making
it
essential
conduct
comparative
analyses
methods
across
domains.
The
diverse
sources
also
pose
challenges
researchers
focusing
on
specific
studies.
In
this
review,
10
categories
drug‐induced
examined,
summarizing
characteristics
applicable
ML
models,
including
both
predictive
interpretable
algorithms,
striking
balance
between
breadth
depth.
Key
databases
tools
used
prediction
highlighted,
toxicology,
chemical,
multi‐omics,
benchmark
databases,
organized
by
their
focus
function
clarify
roles
prediction.
Finally,
strategies
turn
into
opportunities
analyzed
discussed.
This
review
may
provide
with
valuable
reference
understanding
utilizing
available
resources
bridge
mechanistic
insights,
further
advance
application
drugs‐induced
Advanced Healthcare Materials,
Год журнала:
2024,
Номер
13(29)
Опубликована: Авг. 18, 2024
Abstract
Over
the
last
four
decades,
pharmaceutical
companies’
expenditures
on
research
and
development
have
increased
51‐fold.
During
this
same
time,
clinical
success
rates
for
new
drugs
remained
unchanged
at
about
10
percent,
predominantly
due
to
lack
of
efficacy
and/or
safety
concerns.
This
persistent
problem
underscores
need
innovate
across
entire
drug
process,
particularly
in
formulation,
which
is
often
deprioritized
under‐resourced.
Pharmaceutics,
Год журнала:
2024,
Номер
16(7), С. 864 - 864
Опубликована: Июнь 27, 2024
Human
papillomavirus
(HPV)-associated
cervical
cancer
is
the
most
common
among
women
worldwide.
The
treatment
options
are
strongly
related
to
increased
infertility
in
women.
Imiquimod
(IQ)
an
imidazoquinoline,
which
has
proven
antiviral
effects
against
persistent
HPV
infection
by
activating
immune
cells
via
Toll-like
receptors
7/8
when
formulated
carriers,
like
nanogels,
for
topical
use.
An
effective
alternative
conventional
therapies
nanoparticle
drug
delivery
system.
We
studied
lipidic
nanoparticles
with
IQ
(Lipo
IQ)
and
functionalized
them
a
DNA
aptamer,
AT11
AT11),
improve
selectivity
combined
efficacy
of
essential
oils.
formulations
showed
that
physicochemical
properties
adequate
vaginal
have
antimicrobial
activity
at
higher
concentrations
(with
MIC50
starting
from
0.625%).
final
exhibited
cytotoxicity
cells,
enhanced
oils
without
affecting
healthy
resulting
less
than
10%
cell
viability
HeLa
over
60%
NHDF
cells.
Essential
potentiate
Lipo
IQ’s
effectiveness,
while
increases
As
suggested
results
permeation
assay,
were
internalized
Overall,
obtained
synergistic
effect
nanosystem
cytotoxic
promotes
towards